Did Hims & Hers Just Become an AI Company?
Key Points
Hims & Hers announced its strategy around AI and how it fits into the company's platform.
AI could enable more products and solutions for users outside of traditional prescriptions.
- These 10 stocks could mint the next wave of millionaires ›
Hims & Hers (NYSE: HIMS) may not be a name you think of in artificial intelligence, but it should be. The company is building AI tools to help people be healthier, and there's a lot of optionality for the use cases long-term. Management recently outlined some of their vision and investors should expect some launches later this year. If done right, AI is the kind of disruption in healthcare that could make Hims & Hers one of the biggest winners in the market long-term.
*Stock prices used were end-of-day prices of April 3, 2026. The video was published on April 10, 2026.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 946%* — a market-crushing outperformance compared to 190% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
*Stock Advisor returns as of April 10, 2026.
Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
